Loading…

Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation

ABSTRACT Background Existing data on the risk of ischemic stroke in hyperthyroidism‐related atrial fibrillation (AF) and the impact of long‐term anticoagulation in these patients, particularly those with self‐limiting AF, remain inconclusive. Hypothesis Risk of stroke in hyperthyroidism‐related AF i...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cardiology (Mahwah, N.J.) N.J.), 2015-08, Vol.38 (8), p.476-482
Main Authors: Chan, Pak‐Hei, Hai, Jojo, Yeung, Chun‐Yip, Lip, Gregory Y.H., Lam, Karen Siu‐Ling, Tse, Hung‐Fat, Siu, Chung‐Wah
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Background Existing data on the risk of ischemic stroke in hyperthyroidism‐related atrial fibrillation (AF) and the impact of long‐term anticoagulation in these patients, particularly those with self‐limiting AF, remain inconclusive. Hypothesis Risk of stroke in hyperthyroidism‐related AF is the same as nonhyperthyroid counterparts. Methods This was a single‐center observational study of 9727 Chinese patients with nonvalvular AF from July 1997 to December 2011. Patients with AF diagnosed concomitantly with hyperthyroidism were identified. Primary and secondary endpoints were defined as hospitalization with ischemic stroke and intracranial hemorrhage in the first 2 years. Patient characteristics, duration of AF, and choice of antithrombotic therapy were recorded. Self‐limiting AF was defined as
ISSN:0160-9289
1932-8737
DOI:10.1002/clc.22427